Abstract Library

#4239 Implementation of a new, nurse-led clinic (NLC) for neuroendocrine tumor (NET) patients

Introduction: There is international evidence supporting nurse-led services for people with chronic diseases in reducing hospitalisations, symptom improvement and lifestyle, and patient satisfaction. Patients with NET often have high symptoms burden and psychosocial distress in the context of indolent disease. Our centre recently implemented a (NLC) to provide complex care support for patients with NET.

Conference:

Presenting Author:

Authors: Wakelin K, Michael M, Kong G, Rogers M, Natkunarajah N,

Keywords: Nurse-led care, Multidisciplinary care, Supportive care, Symptom management, Patient support,

#4171 Prevalence of sarcopenia in patients with advanced intestinal neuroendocrine neoplasms at time of diagnosis

Introduction: Sarcopenia is defined as the loss of muscle mass, strength, and physical performance. First-line therapy for NENs includes somatostatin analogues (SSAs), which could be responsible for malabsorption conditions (e.g. exocrine pancreatic insufficiency - EPI), that can affect clinical outcomes and treatment response. However, the relationship between sarcopenia and NENs is still lacking in the literature.

Conference:

Presenting Author: Marasco M

Authors: Romano E, Polici M, Lerose F, Marasco M, Nardacci S,

Keywords: malnutrition, sarcopenia, somatostatin analogues, exocrine pancreatic insufficiency,

#3834 The prognostic role of radiomics in gastroenteropancreatic neuroendocrine tumors

Introduction: Gastroenteropancreatic neuroendocrine neoplasia (GEP NENs) are rare and heterogenous diseases.

Conference:

Presenting Author:

Authors: Magi L, Polici M, Rinzivillo M, Caruso D, Zerunian M,

Keywords: radiomics, neuroendocrine tumor, prognosis, disease progression,

#3439 Role of Radiomics in the Everolimus response prediction of metastatic neuroendocrine tumors

Introduction: Radiomics was shown to provide non-invasive imaging biomarkers predicting prognosis and treatment response.

Conference:

Presenting Author: Magi L

Authors: Magi L, Polici M, Zerunian M, Rinzivillo M, Marasco M,

Keywords: response to treatment, Everolimus, neuroendocrine tumor, Radiomics, targeted therapy,

#491 International Survey for the Use of Biomarkers and Molecular Imaging in Neuroendocrine Tumors (NET): What we are Using in Daily Practice

Introduction: Several guidelines have given recommendations for optimal use of biomarkers and molecular imaging. However, those guidelines’ implementation may not be always possible due to local policies or lack of access to several diagnostic studies.

Conference: 9th Annual ENETSConcerence (2012)

Presenting Author:

Authors: Toumpanakis C, Khan M, Bergestuen D, Kim M, Thirlwell C,

Keywords: international survey, biomarker, molecular imaging, NET,